Allspring Global Investments’s Arrowhead Research ARWR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.48M Sell
43,243
-11,936
-22% -$882K 0.01% 960
2026
Q1
$3.47M Buy
55,179
+47,902
+658% +$3.03M 0.01% 936
2025
Q4
$493K Buy
+7,277
New +$357K ﹤0.01% 1382
2024
Q3
Sell
-3,246
Closed -$84.4K 2456
2024
Q2
$84.4K Sell
3,246
-34
-1% -$836 ﹤0.01% 1883
2024
Q1
$93.8K Buy
3,280
+276
+9% +$8.83K ﹤0.01% 1852
2023
Q4
$91.9K Sell
3,004
-2,962
-50% -$78.7K ﹤0.01% 1808
2023
Q3
$160K Sell
5,966
-1,187
-17% -$36.4K ﹤0.01% 1827
2023
Q2
$255K Sell
7,153
-686
-9% -$23.7K ﹤0.01% 1732
2023
Q1
$199K Buy
7,839
+1,768
+29% +$55.6K ﹤0.01% 1822
2022
Q4
$246K Sell
6,071
-86
-1% -$2.85K ﹤0.01% 1780
2022
Q3
$203K Sell
6,157
-193
-3% -$7.79K ﹤0.01% 1808
2022
Q2
$223K Sell
6,350
-37,017
-85% -$1.39M ﹤0.01% 1782
2022
Q1
$1.99M Buy
43,367
+2,834
+7% +$140K ﹤0.01% 1501
2021
Q4
$2.69M Buy
+40,533
New +$2.79M ﹤0.01% 1403

Other funds holding ARWR

Allspring Global Investments's ARWR Position: Q2 2026 in Review

Allspring Global Investments reduced its Arrowhead Research (ARWR) stake by 22% in Q2 2026, selling an estimated $882K and leaving 43,243 shares worth $3.48M. The position accounts for 0.01% of the portfolio, ranked #960.

Allspring Global Investments first reported a position in ARWR in Q4 2021 and has held it in 14 quarters since. 500 funds tracked by Wall St. Rank hold ARWR as of Q2 2026.

  • Allspring Global Investments held 43,243 shares of Arrowhead Research worth $3.48M as of Q2 2026.
  • Allspring Global Investments sold 11,936 Arrowhead Research shares in Q2 2026, an estimated $882K.
  • Arrowhead Research made up 0.01% of Allspring Global Investments's portfolio in Q2 2026, its #960 holding.
  • Allspring Global Investments first reported a position in Arrowhead Research in Q4 2021 and has held it in 14 quarters since.
  • 500 funds tracked by Wall St. Rank held Arrowhead Research as of Q2 2026.

Based on Allspring Global Investments's 13F filing for Q2 2026, filed 13 Aug 2026.